The DOI matches its Crossref record.
Liposome Clearance
Abstract
The clearance rate of liposomal drugs from the circulation is determined by the rate and extent of both drug release and uptake of liposomes by cells of the mononuclear phagocyte system (MPS). Intravenously injected liposomes initially come into contact with serum proteins. The interaction of liposomes with serum proteins is thought to play a critical role in the liposome clearance. Therefore, in this review, we focus on the role of serum proteins, so-called opsonins, that enhance the clearance of liposomes, when bound to liposomes. In addition to opsonin-dependent liposome clearance, opsonin-independent liposome clearance is also reviewed. As opposed to the conventional (non-surface modification) liposomes, we briefly address the issue of the accelerated clearance of PEGylated-liposomes (sterically stabilized liposomes, long-circulating liposomes) on repeated injection, a process that has recently been observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M. W., & Anchordoquy, T. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.013 · Cited by 722
Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 718
Magnetic nanocarriers: Evolution of spinel ferrites for medical applications
Amiri, M., Salavati-Niasari, M., & Akbari, A. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.01.003 · Cited by 651
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Imai, T., Takahashi, Y., Nishikawa, M., Kato, K., Morishita, M., Yamashita, T., Matsumoto, A., Charoenviriyakul, C., & Takakura, Y. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26238 · Cited by 579
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Self-citationRecent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Polymeric materials based on silk proteins
Hardy, J. G., Römer, L. M., & Scheibel, T. R. (2008) · Polymer · doi:10.1016/j.polymer.2008.08.006 · Cited by 506
Gunassekaran, G. R., Poongkavithai Vadevoo, S. M., Baek, M.-C., & Lee, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121137 · Cited by 483
Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles
Jahn, A., Stavis, S. M., Hong, J. S., Vreeland, W. N., DeVoe, D. L., & Gaitan, M. (2010) · ACS Nano · doi:10.1021/nn901676x · Cited by 432
Microfluidic Directed Formation of Liposomes of Controlled Size
Jahn, A., Vreeland, W. N., DeVoe, D. L., Locascio, L. E., & Gaitan, M. (2007) · Langmuir · doi:10.1021/la070051a · Cited by 429
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells
Yanagisawa, K., Moriyasu, F., Miyahara, T., Yuki, M., & Iijima, H. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.08.008 · Cited by 343
Gubernator, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566552 · Cited by 325
Surface Engineering of Liposomes for Stealth Behavior
Nag, O., & Awasthi, V. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040542 · Cited by 322
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Buck, J., Grossen, P., Cullis, P. R., Huwyler, J., & Witzigmann, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b07858 · Cited by 312
Ultralow-Power Near Infrared Lamp Light Operable Targeted Organic Nanoparticle Photodynamic Therapy
Huang, L., Li, Z., Zhao, Y., Zhang, Y., Wu, S., Zhao, J., & Han, G. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05390 · Cited by 301
Silk microspheres for encapsulation and controlled release
Wang, X., Wenk, E., Matsumoto, A., Meinel, L., Li, C., & Kaplan, D. L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.021 · Cited by 293
Evolution and clinical translation of drug delivery nanomaterials
Hassan, S., Prakash, G., Bal Ozturk, A., Saghazadeh, S., Farhan Sohail, M., Seo, J., Remzi Dokmeci, M., Zhang, Y. S., & Khademhosseini, A. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.008 · Cited by 288
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 278
Liposome and immune system interplay: Challenges and potentials
Zahednezhad, F., Saadat, M., Valizadeh, H., Zakeri-Milani, P., & Baradaran, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.030 · Cited by 267
Preparation of nanoparticles by continuous-flow microfluidics
Jahn, A., Reiner, J. E., Vreeland, W. N., DeVoe, D. L., Locascio, L. E., & Gaitan, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-007-9340-5 · Cited by 260
Huda, M. N., Nafiujjaman, M., Deaguero, I. G., Okonkwo, J., Hill, M. L., Kim, T., & Nurunnabi, M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00217 · Cited by 254
Advances in lipid nanoparticles for siRNA delivery
Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229
Kierstead, P. H., Okochi, H., Venditto, V. J., Chuong, T. C., Kivimae, S., Fréchet, J. M. J., & Szoka, F. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.023 · Cited by 210
Yanar, F., Carugo, D., & Zhang, X. (2023) · Molecules · doi:10.3390/molecules28155694 · Cited by 80
Shiraishi, K., Sanada, Y., Mochizuki, S., Kawano, K., Maitani, Y., Sakurai, K., & Yokoyama, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.017 · Cited by 51
In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids
Liu, F., Yang, L., Li, Y., Junier, A., Ma, F., Chen, J., Han, H., Glass, Z., Zhao, X., Kumamoto, C. A., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01722 · Cited by 21
Oral colon cancer targeting by chitosan nanocomposites
Bose, A., & Wong, T. W. (2018) · Applications of Nanocomposite Materials in Drug Delivery · doi:10.1016/b978-0-12-813741-3.00018-2 · Cited by 12
Metadata
- Authors
- Ishida, T., Harashima, H., & Kiwada, H.
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2002-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 197-224
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- OpenAlex
- W4235358290
- Cited by
- 330
- References
- 0
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.